Gene Expression During C2C12 Differentiation

Zoe Storaasli,Yan Zhao,Marlin Touma
DOI: https://doi.org/10.15695/vurj.v14i1.5511
2024-07-06
Vanderbilt Undergraduate Research Journal
Abstract:Congenital heart disease (CHD) is one of the most common types of birth defect and is very poorly understood. To comprehend this disease better, the normal genetic expression associated with myocyte differentiation must be mapped out. This gives a deeper understanding of how cardiomyocytes (cardiac muscle cells) divide and specialize, which can contribute to understanding the mechanisms of CHD better. The workflow of this specific project began with culturing C2C12 mouse muscle myoblast cells and harvesting them at six different time points: 50% confluency, 100% confluency, 24-hours postdifferentiation, 48-hour postdifferentiation, 72-hour postdifferentiation, and 96-hour postdifferentiation. The expression levels of MyoD1, Myogenin, MyoM2, MyoZ2, GATA4, TbX5, NKX2.5, Ki67, Tcap, and RBFox1 were then measured and compared with qPCR. It was expected that those gene markers associated with muscle differentiation and structure would increase in expression levels over time while those markers associated with cell proliferation would decrease in expression levels. The qPCR showed the expected induction of myogenic differentiation marker genes, with the following deviation: MyoD1 expression did not increase during differentiation, and cardiogenesis markers did not follow a clear expression pattern during differentiation. Future studies on human-induced pluripotent stem cells differentiation to cardiomyocytes are needed to understand the patterns of gene expression in cardiomyocytes compared to skeletal myocytes. The outcomes of these studies may contribute to a deeper understanding of heart development and abnormalities in patients with CHD, and may improve diagnosis and treatment methods.
What problem does this paper attempt to address?